|
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study |
|
|
|
Titel: |
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study |
Auteur: |
Zhou, Qing Xu, Chong-Rui Cheng, Ying Liu, Yun-Peng Chen, Gong-Yan Cui, Jiu-Wei Yang, Nong Song, Yong Li, Xiao-Ling Lu, Shun Zhou, Jian-Ying Ma, Zhi-Yong Yu, Shi-Ying Huang, Cheng Shu, Yong-Qian Wang, Zhen Yang, Jin-Ji Tu, Hai-Yan Zhong, Wen-Zhao Wu, Yi-Long |
Verschenen in: |
Cancer cell |
Paginering: |
Jaargang 39 () nr. 9 pagina's 1279-1291.e3 |
Jaar: |
2021 |
Inhoud: |
|
Uitgever: |
Elsevier Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|